We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Merck Strategy Still Murky As Jury Mulls Vioxx Claims

Law360 (July 12, 2006, 12:00 AM EDT) -- For Merck & Co. to successfully defend itself against more than 13,000 lawsuits over the former blockbuster drug Vioxx, the case deliberated Wednesday by a New Jersey jury seems like a must-win.

The plaintiff in the lawsuit, Elaine Doherty, is blaming Vioxx for a heart attack she suffered in January 2004 after taking the drug for arthritis for 2 1/2 years.

Yet the 68-year-old homemaker also suffered from severely clogged arteries, obesity, high blood pressure, a cholesterol problem, a family history of heart disease and an...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.